Critical Appraisal Bias - Blinding/Follow Up Flashcards

1
Q

Why do we blind Patients

A

To prevent placebo effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why do we blind Clinicians

A

To prevent cointerventions
- Additional procedures to sway the data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why do we blind Data Collectors

A

To prevent bias in collection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do we blind Outcome Adjudicators

A

To prevent bias in decisions regarding outcomes
- When deciding who has what outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why do we blind Data Analysts

A

To avoid bias in decisions regarding data analysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Open Label Study

A

No blinding
- Clinicians and Patients no which intervention they have

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PROBE Design

A

Patient and Clinician can not be blinded

Can blind Outcome Adjudicators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to control placebo

A

Blinding

Make outcomes less subjective

Ask patients at the end if they think they received

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contamination

A

Patient receives treatment from the other group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why is loss of follow up important

A

If the patient is lost to follow up then the study wont be able to record their events and outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Loss To Follow Up
- Rule of Thumb

A

5% Rule
- If 5% or below then risk of bias is low and we can tolerate the

20% Rule
- If 20% or higher than risk of bias is high and we can not trust the data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Loss of Follow Up is between 5% and 20%

A

Assume worst case scenario
- The minimal effect the intervention can have

Even in the worst case there is still benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Patients lost in follow up vs patients remaining

A

Both groups have different prognosis
- Usually the patients lost to follow up either are much sicker or much healthier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alternative to 5% and 20% rule

A

Assume worst case scenario

So for an experimental treatment that reduces a bad event
- Assume the patient’s outcome was the bad effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How to deal with missing data
- Single Imputation

A
  • Carry last observable outcome forward
  • Replace with average value of all participants
  • Use regression model to predict missing value based on trends
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to deal with missing data
- Multiple Imputation

A
  • Use regression methods and perform standard analysis for each imputation cycle
    –> Final analysis takes into consideration variability from multiple imputation cycles
17
Q

Sensitivity Analysis

A

To assess the effect of missing data
- If the data remains consistient even after slowly changing different variables after multiple imputation then you can trust the data

18
Q

What does Loss to Follow Up depend on

A

Does NOT depend on total number of LTF

Depends on number of events in each group

19
Q

LTF with low risk of bias

A

For low risk of bias
- Investigators need to demonstrate that prognostic is similar between group that remains and group LTF
- Even when assuming worst case there is little change in results